Inzaule, S;
              
      
            
                Silva, R;
              
      
            
                Ford, N;
              
      
            
                Thwin, SS;
              
      
            
                Waasila, J;
              
      
            
                Zumla, A;
              
      
            
                Doherty, M;
              
      
            
            
          
      
            
            
            ... Bertagnolio, S; + view all
            
          
      
        
        
        
    
  
(2025)
  Comparative analyses of COVID-19 in-hospital mortality in people living with HIV during SARS-CoV-2 pre-delta, delta, and omicron waves: data from the who global clinical platform.
AIDS
      
    
    
    
         10.1097/QAD.0000000000004323.
   (In press).
  
| ![[thumbnail of comparative_analyses_of_covid_19_in_hospital.761.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) | Text comparative_analyses_of_covid_19_in_hospital.761.pdf - Accepted Version Access restricted to UCL open access staff until 15 August 2026. Download (933kB) | 
Abstract
Background: We investigated in-hospital mortality trends across waves of different SARS-CoV-2 variants and assessed the effect of COVID-19 immunization among PLHIV. Method: We analyzed individual-level data from the WHO Global Clinic Platform comprising 823,845 hospitalized children and adults from 61 countries. Survival analyses was used to assess the association of HIV co-infection with in-hospital mortality across SARS-CoV-2 pre-Delta, Delta and Omicron variant waves. Findings: PLHIV experienced significantly higher in-hospital mortality compared to HIV-negative individuals across all variant waves. Adjusted hazard ratios (aHRs) for PLHIV mortality were 1.85 (95%CI 1.76-1.93) during the pre-Delta wave, 1.58 (95%CI 1.42-1.74) during the Delta wave, and 3.07 (95%CI 2.75-3.42) during the Omicron wave. In-hospital mortality risk was notably higher in PLHIV with CD4 ≤200 cells/mm<sup>3</sup>. While mortality declined modestly between pre-Delta and Delta waves in both HIV-negative (10% reduction) and HIV-positive populations (9% reduction), the decline was more substantial for HIV-negative individuals during the Omicron wave (from 18.9% to 8.0%) than for PLHIV (from 24.2% to 19.3%) relative to the Delta wave. Interpretation: Although in-hospital mortality among HIV-negative individuals declined markedly during the Omicron wave, reduction in PLHIV was less pronounced, leading to a relatively higher mortality risk for this group. These findings highlight the need for adherence to WHO recommendations on booster vaccinations and therapeutics for populations at elevated risk of severe COVID-19 outcomes, including PLHIV.
| Type: | Article | 
|---|---|
| Title: | Comparative analyses of COVID-19 in-hospital mortality in people living with HIV during SARS-CoV-2 pre-delta, delta, and omicron waves: data from the who global clinical platform | 
| Location: | England | 
| DOI: | 10.1097/QAD.0000000000004323 | 
| Publisher version: | http://dx.doi.org/10.1097/QAD.0000000000004323 | 
| Language: | English | 
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. | 
| Keywords: | COVID-19, HIV, Mortality, PLHIV, SARS-CoV2, Vaccine | 
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity | 
| URI: | https://discovery.ucl.ac.uk/id/eprint/10213346 | 
Archive Staff Only
|  | View Item | 
 
                      
